View Item 

Show simple item record

An Emergency Medicine–focused Summary of the HFSA/SAEM/ISHLT Clinical Consensus Document on the Emergency Management of Patients With Ventricular Assist Devices
dc.contributor.authorDarling, Chad E.
dc.contributor.authorMartindale, Jennifer L.
dc.contributor.authorHiestand, Brian C.
dc.contributor.authorBonnell, Mark
dc.contributor.authorColvin, Monica
dc.contributor.authorDeFilippis, Ersilia M.
dc.contributor.authorElliott, Tonya
dc.contributor.authorHamad, Eman
dc.contributor.authorPinney, Sean P.
dc.contributor.authorShah, Keyur B.
dc.contributor.authorVierecke, Juliane
dc.contributor.authorGivertz, Michael M.
dc.date.accessioned2020-08-10T20:54:42Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-08-10T20:54:42Z
dc.date.issued2020-07
dc.identifier.citationDarling, Chad E.; Martindale, Jennifer L.; Hiestand, Brian C.; Bonnell, Mark; Colvin, Monica; DeFilippis, Ersilia M.; Elliott, Tonya; Hamad, Eman; Pinney, Sean P.; Shah, Keyur B.; Vierecke, Juliane; Givertz, Michael M. (2020). "An Emergency Medicine–focused Summary of the HFSA/SAEM/ISHLT Clinical Consensus Document on the Emergency Management of Patients With Ventricular Assist Devices." Academic Emergency Medicine 27(7): 618-629.
dc.identifier.issn1069-6563
dc.identifier.issn1553-2712
dc.identifier.urihttps://hdl.handle.net/2027.42/156194
dc.description.abstractMechanical circulatory support is increasingly used as a long‐term treatment option for patients with end‐stage heart failure. Patients with implanted ventricular assist devices are at high risk for a range of diverse medical urgencies and emergencies. Given the increasing prevalence of mechanical circulatory support devices, this expert clinical consensus document seeks to help inform emergency medicine and prehospital providers regarding the approach to acute medical and surgical conditions encountered in these complex patients.
dc.publisherWiley Periodicals, Inc.
dc.titleAn Emergency Medicine–focused Summary of the HFSA/SAEM/ISHLT Clinical Consensus Document on the Emergency Management of Patients With Ventricular Assist Devices
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156194/2/acem13964_am.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156194/1/acem13964.pdfen_US
dc.identifier.doi10.1111/acem.13964
dc.identifier.sourceAcademic Emergency Medicine
dc.identifier.citedreferenceMonkowski DH, Axelrod P, Fekete T, Hollander T, Furukawa S, Samuel R. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis 2007; 9: 114 – 20.
dc.identifier.citedreferenceRay R, Kale PP, Ha R, Banerjee D. Treatment of left ventricular assist device‐associated arteriovenous malformations with thalidomide. ASAIO J 2014; 60: 482 – 3.
dc.identifier.citedreferenceAcharya D, Loyaga‐Rendon R, Morgan CJ, et al. INTERMACS analysis of stroke during support with continuous‐flow left ventricular assist devices: risk factors and outcomes. JACC Heart Fail 2017; 5: 703 – 11.
dc.identifier.citedreferenceParikh NS, Cool J, Karas MG, Boehme AK, Kamel H. Stroke risk and mortality in patients with ventricular assist devices. Stroke 2016; 47: 2702 – 6.
dc.identifier.citedreferenceHarvey L, Holley C, Roy SS, et al. Stroke after left ventricular assist device implantation: outcomes in the continuous‐flow era. Ann Thorac Surg 2015; 100: 535 – 41.
dc.identifier.citedreferenceFrontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant 2017; 36: 673 – 83.
dc.identifier.citedreferenceGodoy DA, Piñero GR, Koller P, Masotti L, Di Napoli M. Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage. World J Crit Care Med 2015; 4: 213 – 29.
dc.identifier.citedreferenceKrstic A, O’Carroll C, Lanza L, Steidley DE, Staley L, Cartin‐Ceba R. 1276: simultaneous LVAD thrombosis and ischemic stroke treated successfully with alteplase. Crit Care Med 2015; 43: 321.
dc.identifier.citedreferenceHannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 2011; 30: 375 – 84.
dc.identifier.citedreferenceMiller LW, Guglin M. Patient selection for ventricular assist devices: a moving target. J Am Coll Cardiol 2013; 61: 1209 – 21.
dc.identifier.citedreferenceMiller LW, Pagani FD, Russell SD, et al. Use of a continuous‐flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885 – 96.
dc.identifier.citedreferencePagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous‐flow rotary left ventricular assist device. J Am Coll Cardiol 2009; 54: 312 – 21.
dc.identifier.citedreferenceSharma V, Deo SV, Stulak JM, et al. Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 2012; 94: 1381 – 6.
dc.identifier.citedreferenceNienaber JJC, Kusne S, Riaz T, et al. Clinical manifestations and management of left ventricular assist device‐associated infections. Clin Infect Dis 2013; 57: 1438 – 48.
dc.identifier.citedreferenceBaddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: e394 – 434.
dc.identifier.citedreferenceSandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015; 70: 325 – 59.
dc.identifier.citedreferenceMehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in long‐term mechanical circulatory support. J Heart Lung Transplant 2014; 33: 1 – 11.
dc.identifier.citedreferenceTchantchaleishvili V, Sagebin F, Ross RE, Hallinan W, Schwarz KQ, Massey HT. Evaluation and treatment of pump thrombosis and hemolysis. Ann Cardiothorac Surg 2014; 3: 490 – 5.
dc.identifier.citedreferenceGoldstein DJ, John R, Salerno C, et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant 2013; 32: 667 – 70.
dc.identifier.citedreferenceSylvia LM, Ordway L, Pham DT, DeNofrio D, Kiernan M. Bivalirudin for treatment of LVAD thrombosis: a case series. ASAIO J 2014; 60: 744 – 7.
dc.identifier.citedreferenceSchrage B, Grahn H, Wagner FM, et al. Effective treatment with a new protocol using tissue‐type plasminogen activator thrombolysis for pump thrombosis with the HVAD device. Eur Heart J Acute Cardiovasc Care 2018; 7: 766 ‐ 70.
dc.identifier.citedreferenceBasken R, Bazzell CM, Smith R, Janardhanan R, Khalpey Z. Advantages and disadvantages of using intravenous tissue plasminogen activator as salvage therapy for inoperable HeartWare thrombosis. J Card Surg 2017; 32: 443 ‐ 6.
dc.identifier.citedreferenceUpshaw JN, Kiernan MS, Morine KJ, Kapur NK, DeNofrio D. Incidence, management, and outcome of suspected continuous‐flow left ventricular assist device thrombosis. ASAIO J 2016; 62: 33 – 9.
dc.identifier.citedreferenceKirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 2015; 34: 1495 – 504.
dc.identifier.citedreferenceWever‐Pinzon O, Givens RC, Flannery M, Naka Y, Jorde UP. Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: the short‐to‐shield phenomenon. J Heart Lung Transplant 2015; 34: 270 – 1.
dc.identifier.citedreferenceKornberger A, Stock UA, Risteski P, Beiras Fernandez A. Left ventricular non‐compaction cardiomyopathy and left ventricular assist device: a word of caution. J Cardiothorac Surg 2016; 11: 108.
dc.identifier.citedreferenceAbraham J, Remick JD, Caulfield T, et al. Left ventricular assist device outflow cannula obstruction treated with percutaneous endovascular stenting. Circ Heart Fail 2015; 8: 229 – 30.
dc.identifier.citedreferenceGivertz MM, DeFilippis EM, Colvin M, et al. HFSA/SAEM/ISHLT clinical expert consensus document on the emergency management of patients with ventricular assist devices. J Card Fail 2019; 25: 494 – 515.
dc.identifier.citedreferenceStewart GC, Givertz MM. Mechanical circulatory support for advanced heart failure: patients and technology in evolution. Circulation 2012; 125: 1304 – 15.
dc.identifier.citedreferenceKirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant 2017; 36: 1080 – 6.
dc.identifier.citedreferenceSmith LA, Yarboro LT, Kennedy JL. Left ventricular assist device implantation strategies and outcomes. J Thorac Dis 2015; 7: 2088 – 96.
dc.identifier.citedreferenceSlaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous‐flow left ventricular assist device. N Engl J Med 2009; 361: 2241 – 51.
dc.identifier.citedreferenceMehra MR, Naka Y, Uriel N, et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 2017; 376: 440 – 50.
dc.identifier.citedreferenceUriel N, Colombo PC, Cleveland JC, et al. Hemocompatibility‐related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure. Circulation 2017; 135: 2003 – 12.
dc.identifier.citedreferenceMyers TJ, Bolmers M, Gregoric ID, Kar B, Frazier OH. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant 2009; 28: 423 – 7.
dc.identifier.citedreferenceLanier GM, Orlanes K, Hayashi Y, et al. Validity and reliability of a novel slow cuff‐deflation system for noninvasive blood pressure monitoring in patients with continuous‐flow left ventricular assist device. Circ Heart Fail 2013; 6: 1005 – 12.
dc.identifier.citedreferenceFeldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013; 32: 157 – 87.
dc.identifier.citedreferenceOleyar M, Stone M, Neustein SM. Perioperative management of a patient with a nonpulsatile left ventricular‐assist device presenting for noncardiac surgery. J Cardiothorac Vasc Anesth 2010; 24: 820 – 3.
dc.identifier.citedreferenceCook JL, Colvin M, Francis GS, et al. Recommendations for the use of mechanical circulatory support: ambulatory and community patient care: a scientific statement from the American Heart Association. Circulation 2017; 135: e1145 – 58.
dc.identifier.citedreferenceGarg S, Ayers CR, Fitzsimmons C, et al. In‐hospital cardiopulmonary arrests in patients with left ventricular assist devices. J Card Fail 2014; 20: 899 – 904.
dc.identifier.citedreferenceMabvuure NT, Rodrigues JN. External cardiac compression during cardiopulmonary resuscitation of patients with left ventricular assist devices. Interact Cardiovasc Thorac Surg 2014; 19: 286 – 9.
dc.identifier.citedreferenceYuzefpolskaya M, Uriel N, Flannery M, et al. Advanced cardiovascular life support algorithm for the management of the hospitalized unresponsive patient on continous flow left ventricular assist device support outside the intensive care unit. Eur Heart J Acute Cardiovasc Care 2016; 5: 522 ‐ 6.
dc.identifier.citedreferencePeberdy MA, Gluck JA, Ornato JP, et al. Cardiopulmonary resuscitation in adults and children with mechanical circulatory support: a scientific statement from the American Heart Association. Circulation 2017; 135: e1115 – 34.
dc.identifier.citedreferenceRaasch H, Jensen BC, Chang PP, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous‐flow left ventricular assist device implantation. Am Heart J 2012; 164: 373 – 8.
dc.identifier.citedreferenceFried J, Garan AR, Shames S, et al. Aortic root thrombosis in patients supported with continuous‐flow left ventricular assist devices. J Heart Lung Transplant 2018; 37: 1425 – 32.
dc.identifier.citedreferenceTanna MS, Reyentovich A, Balsam LB, et al. Aortic root thrombus complicated by left main coronary artery occlusion visualized by 3D echocardiography in a patient with continuous‐flow left ventricular assist device. Echocardiography 2017; 34: 306 – 10.
dc.identifier.citedreferenceSpina R, Siriwardena M, Bart N, et al. Primary percutaneous coronary intervention for inferior ST‐segment elevation myocardial infarction in a patient supported by the HeartWare left ventricular assist device. Intern Med J 2017; 47: 1068 – 71.
dc.identifier.citedreferenceDang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006; 25: 1 – 6.
dc.identifier.citedreferenceBurke MA, Givertz MM. Assessment and management of heart failure after left ventricular assist device implantation. Circulation 2014; 129: 1161 – 6.
dc.identifier.citedreferenceATLS Subcommittee, American College of Surgeons’ Committee on Trauma, International ATLS Working Group. Advanced Trauma Life Support (ATLS®): the ninth edition. J Trauma Acute Care Surg 2013; 74: 1363 – 6.
dc.identifier.citedreferenceHussmann B, Lendemans S. Pre‐hospital and early in‐hospital management of severe injuries: changes and trends. Injury 2014; 45 ( Suppl 3 ): S39 – 42.
dc.identifier.citedreferenceStulak JM, Schettle S, Haglund N, et al. Percutaneous driveline fracture following implantation of the HeartMate II left ventricular assist device: how durable is driveline repair? ASAIO J 2017; 63: 542 – 5.
dc.identifier.citedreferenceCrow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009; 137: 208 – 15.
dc.identifier.citedreferenceWever‐Pinzon O, Selzman CH, Drakos SG, et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous‐flow left ventricular assist device HeartMate II. Circ Heart Fail 2013; 6: 517 – 26.
dc.identifier.citedreferenceNascimbene A, Neelamegham S, Frazier OH, Moake JL, Dong JF. Acquired von Willebrand syndrome associated with left ventricular assist device. Blood 2016; 127: 3133 – 41.
dc.identifier.citedreferenceUriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous‐flow mechanical device support contributes to a high prevalence of bleeding during long‐term support and at the time of transplantation. J Am Coll Cardiol 2010; 56: 1207 – 13.
dc.identifier.citedreferenceCrow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous‐flow ventricular assist device recipients. Ann Thorac Surg 2010; 90: 1263 – 9; discussion 1269.
dc.identifier.citedreferenceSparrow CT, Nassif ME, Raymer DS, Novak E, LaRue SJ, Schilling JD. Pre‐operative right ventricular dysfunction is associated with gastrointestinal bleeding in patients supported with continuous‐flow left ventricular assist devices. JACC Heart Fail 2015; 3: 956 – 64.
dc.identifier.citedreferenceDraper KV, Huang RJ, Gerson LB. GI bleeding in patients with continuous‐flow left ventricular assist devices: a systematic review and meta‐analysis. Gastrointest Endosc 2014; 80: 435 – 46.e1.
dc.identifier.citedreferenceMehra MR, Goldstein DJ, Uriel N, et al. Two‐year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med 2018; 378: 1386 – 95.
dc.identifier.citedreferenceAxelrad JE, Pinsino A, Trinh PN, et al. Limited usefulness of endoscopic evaluation in patients with continuous‐flow left ventricular assist devices and gastrointestinal bleeding. J Heart Lung Transplant 2018; 37: 723 – 32.
dc.identifier.citedreferenceAggarwal A, Pant R, Kumar S, et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012; 93: 1534 – 40.
dc.identifier.citedreferenceDemirozu ZT, Radovancevic R, Hochman LF, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011; 30: 849 – 53.
dc.identifier.citedreferenceHayes HM, Dembo LG, Larbalestier R, O’Driscoll G. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single‐center experience. Artif Organs 2010; 34: 703 – 6.
dc.identifier.citedreferenceDraper K, Kale P, Martin B, Cordero K, Ha R, Banerjee D. Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol. J Heart Lung Transplant 2015; 34: 132 – 4.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acem13964.pdf
Size:
516.7KB
Format:
PDF
View/Open
Name:
acem13964_am.pdf
Size:
465.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.